Merck Expects Delay for a Hepatitis C Therapy by REUTERS

By REUTERS

The company said regulators intended to rescind the “breakthrough therapy” designation for its treatment because other new drugs were available.

Published: February 5, 2015 at 12:00AM

from NYT Business Day http://ift.tt/16quEKa

from WordPress http://ift.tt/1CwsF4Y

via Hadi Aboukhater